Thursday, October 22, 2026

Palantir's AI platform keeps winning partners and upgrades, even as defense analysts turn gloomy and the stock slides

Analysts upgraded Palantir on customer expansion and the finding that customer-built AI apps complement its platform. Partnerships ran from banking to sovereign AI. The stock still fell five sessions in a row, and J.P. Morgan was cautious on defense. Every claim here is tied to a named source.

LM Salvado

October 21, 2026

Palantir's AI platform keeps winning partners and upgrades, even as defense analysts turn gloomy and the stock slides
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

The AI question analysts are settling

The most useful AI-industry argument in this week's Palantir coverage is about build versus buy. Ryan Canady upgraded Palantir to Buy after concluding that customer-built AI applications can remain complementary to Palantir's platforms rather than displace its core offering.1 Many practitioners worry that companies will assemble their own AI apps on top of general models and skip the platform vendor. Canady's view is that the two coexist.

Bernard Zambonin stays constructive too. He emphasizes customer expansion and net dollar retention as central to the bull case. He also acknowledges that the elevated forward valuation makes continued execution essential.1 Net dollar retention measures how much existing customers spend year over year. In this case it is the evidence that customers are staying and buying more. Our dossier contains no figure for it, so we cannot say how high it is.

A run of partnerships in four days

The deal flow is the other half of the technology story. On October 13, Ondas and Palantir announced Regna AI, a standalone private company to help governments, businesses and institutions develop and deploy AI models in sovereign environments. Palantir is expected to provide model-training infrastructure and engineering.2 On October 14, Customers Bank announced a collaboration with Palantir to develop an AI-oriented banking operating model. Its forward-looking statements highlight implementation risks, reliability concerns and contractual flexibility.3

The same day, Surf Air Mobility announced its fifth commercial OperatorOS agreement, with Flying Zebra, using software powered by Palantir. Surf Air receives a percentage of revenue from trips managed through the platform.4 The deals span government, banking and aviation software. In the bank deal, the partner's own filing language flags reliability concerns. That caution is worth keeping next to the enthusiasm.

The stock did not follow the headlines

Palantir (PLTR) sank more than 7% on Friday, October 16, closing at $186.03, down $14.47. It was the fifth lower close in a row, coming off a 52-week high of $212.94 set early that week.1 The decline came amid a broader technology sector selloff.1 So analyst upgrades and a burst of partnerships did not stop the slide. In that sell-off, the broader market weighed more than the company-specific news.

If you hold a broad technology fund, you may already own Palantir. Our dossier does not give its weighting in any index, so we will not guess at it.

The defense backdrop

Palantir sells to governments, so the defense mood matters. J.P. Morgan's lead aerospace and defense analyst, Seth M. Seifman, downgraded Leidos on October 8. His reasoning was that Leidos' relatively low valuation is insufficient to justify an Overweight rating when other aerospace and defense stocks also offer substantial potential returns.5 He expects most aerospace and defense companies to deliver solid Q3 results and express confidence in underlying demand. But good earnings may not reverse the sector's stock-market weakness.5 J.P. Morgan cites slowing airline traffic growth, uncertainty over U.S. military spending and lingering supply-chain constraints.5

Seifman is not bearish on everything. He expects Howmet's 2026 earnings estimates to increase and management to stay confident about growth in aerospace and industrial gas turbines.5 The weakness is about sentiment and budgets, not a collapse in demand. The November 3 congressional midterm elections could change congressional control and constrain military spending growth. Some of the uncertainty may fade after that date.6

Our knowledge graph also records that BigBear.ai Holdings competes with Leidos Holdings.7 It is a reminder that the AI-for-government field has several players. Our dossier does not say how BigBear.ai's results compare with Palantir's or Leidos'.

How far to trust each source

Both the Palantir and the Leidos articles come from NewsEOD. Our own checks found that 58% of 927 checked claims from that source held up.1,5 That is a middling record, so read the specifics, such as the closing price and the analyst attributions, as reported rather than independently confirmed. The Via News verified data in this dossier concerns Goldman Sachs' financial filings. It has no bearing on Palantir, and we do not use it here.

Not everything in the original brief is supported. The brief names Fiorillo and Zaccardi among the bullish analysts, but our source material contains only Zambonin's and Canady's positions. We also have no source text for the Armada sovereign-infrastructure announcement. We leave both out rather than fill the gap.

What to watch

  • November 3: the midterm elections, which could change congressional control and constrain military spending growth.6
  • Whether the Regna AI venture shows how sovereign-environment AI work gets done, given Palantir's expected role in training infrastructure and engineering.2
  • Whether the Customers Bank collaboration addresses the reliability and implementation risks its own statements flag.3
  • Whether Palantir's streak of lower closes ends, and whether the $212.94 high is retested. The upgrades say the business is healthy. The valuation caveat Zambonin raises says the market wants proof.1

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score12 source documents12 with a live linkVerifiability: Strong
  1. [1]News articleYahoo Finance· July 11, 2026
    173-year-old denim giant sees one fashion trend surge 70%
  2. [2]News articleNasdaq· July 3, 2026
    Bull of the Day: Bloom Energy (BE)
  3. [3]News articleSeeking Alpha· July 28, 2026
    D-Wave Quantum dips 10%, moderating previous day's rally
  4. [4]News articleSeeking Alpha· June 24, 2026
    KB Home outlines Q3 2026 housing revenue $1.2B-$1.35B with gross margin 16%-16.6%
  5. [5]News articleSeeking Alpha· October 8, 2026
    Leidos downgraded by J.P. Morgan as defense stocks face rocky earnings season
  6. [6]News articleMotley Fool
    NuScale Power Stock Will Spike 23.7% Over the Next 11 Months According to This Wall Street Analyst
  7. [7]News articleSeeking Alpha· October 16, 2026
    Palantir Technologies declines 7% amid broader tech selloff
  8. [8]News articleMotley Fool
    Why Iovance Biotherapeutics Stock Was on Fire Today
  9. [9]News articleMotley Fool
    Why Wendy's Stock Withered on Wednesday
  10. [10]News articleSeeking Alpha· September 30, 2026
    FactSet expects 5% to 6.5% organic ASV growth in FY '27 while pointing to 25 to 75 bps margin improvement
  11. [11]News articleSeeking Alpha· July 29, 2026
    Landstar outlines July truck revenue per load up about 26% year-over-year while shifting to Q3 commentary over guidance
  12. [12]News articleSeeking Alpha· October 6, 2026
    RPM projects fiscal 2027 mid-single-digit sales and adjusted EBITDA growth as Q2 raw material inflation rises to 9%–11%
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Crunch: Late-Stage Readouts and Regulatory Milestones Converge on the Ivonescimab PDUFA Date
October 2026 is dense with clinical and regulatory news. Phase 3 trials hit primary endpoints (ALOFT-IPF, RESTORE-3), long-term data came out (MIUDELLA at 6 years, QUILT-3.032), and the FDA accepted Roche's vamikibart BLA. Scholar Rock resubmitted its apitegromab MAA to the EMA. The next catalysts are ESMO 2026 (Oct 23) and the Nov 14 FDA PDUFA date for ivonescimab, followed by Maritime-1 primary completion in January 2027. The speculative QAIAx items (QIII pilot, microcities patent) are a weak, tangential thread with little financial substance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,426 source documents archived
Query this data → isubstrate.com